Damora Therapeutics, Inc. — All Filings
315 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-124487 | Mar 25, 2026 | Mar 23, 2026 |
| 4 | 4 | 0001193125-26-124483 | Mar 25, 2026 | Mar 23, 2026 |
| 4 | 4 | 0001193125-26-124476 | Mar 25, 2026 | Mar 23, 2026 |
| 4 | 4 | 0001193125-26-124471 | Mar 25, 2026 | Mar 23, 2026 |
| 4 | 4 | 0001193125-26-124466 | Mar 25, 2026 | Mar 23, 2026 |
| 4 | 4 | 0001193125-26-124455 | Mar 25, 2026 | Mar 23, 2026 |
| 3 | 3 | 0001193125-26-124447 | Mar 25, 2026 | Mar 23, 2026 |
| 3 | 3 | 0001193125-26-124440 | Mar 25, 2026 | Mar 23, 2026 |
| 8-K | 8-K | 0001193125-26-118699 | Mar 23, 2026 | Mar 20, 2026 |
| S-8 | S-8 | 0001193125-26-117594 | Mar 20, 2026 | — |
| 10-K | 10-K | 0001193125-26-115922 | Mar 19, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-099404 | Mar 10, 2026 | Mar 6, 2026 |
| SCHEDULE 13G/A | — | 0001193125-26-096746 | Mar 6, 2026 | — |
| SCHEDULE 13G | — | 0001738048-26-000036 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-001154 | Feb 17, 2026 | — |
| 4 | 4 | 0001193125-26-047537 | Feb 12, 2026 | Feb 9, 2026 |
| 4 | 4 | 0001193125-26-047535 | Feb 12, 2026 | Feb 9, 2026 |
| SCHEDULE 13D/A | — | 0001193125-26-047007 | Feb 11, 2026 | — |
| 8-K | 8-K | 0001193125-26-046817 | Feb 11, 2026 | Feb 10, 2026 |
| 424B5 | 424B5 | 0001193125-26-046779 | Feb 11, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-044766 | Feb 10, 2026 | — |
| S-3ASR | S-3ASR | 0001193125-26-044613 | Feb 10, 2026 | — |
| 8-K | 8-K | 0001193125-26-043741 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | 4 | 0001193125-26-023094 | Jan 26, 2026 | Jan 5, 2026 |
| 3 | 3 | 0001193125-26-023089 | Jan 26, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | — | 0001193125-26-010366 | Jan 12, 2026 | — |
| SCHEDULE 13G | — | 0001193125-26-010344 | Jan 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-009812 | Jan 12, 2026 | — |
| 4 | 4 | 0001193125-26-006723 | Jan 7, 2026 | Jan 5, 2026 |
| 3 | 3 | 0001193125-26-006720 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-004573 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-004568 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-004565 | Jan 6, 2026 | Jan 2, 2026 |
| 8-K | 8-K | 0001193125-26-003490 | Jan 6, 2026 | Dec 31, 2025 |
| S-8 | S-8 | 0001193125-26-001076 | Jan 2, 2026 | — |
| DEF 14A | DEF 14A | 0001140361-25-047056 | Dec 31, 2025 | Feb 9, 2026 |
| 424B3 | 424B3 | 0001193125-25-338281 | Dec 31, 2025 | — |
| EFFECT | — | 9999999995-25-003922 | Dec 23, 2025 | — |
| PRE 14A | PRE 14A | 0001140361-25-045696 | Dec 16, 2025 | — |
| S-3 | S-3 | 0001193125-25-321093 | Dec 16, 2025 | — |
| 8-K/A | 8-K/A | 0001193125-25-312912 | Dec 9, 2025 | Nov 10, 2025 |
| SCHEDULE 13G | — | 0001193125-25-309825 | Dec 5, 2025 | — |
| SCHEDULE 13G | — | 0000315066-25-002950 | Dec 5, 2025 | — |
| D | — | 0001193125-25-291332 | Nov 21, 2025 | — |
| 3 | 3 | 0001193125-25-285077 | Nov 17, 2025 | Nov 10, 2025 |
| 3 | 3 | 0001193125-25-285071 | Nov 17, 2025 | Nov 10, 2025 |
| SCHEDULE 13D | — | 0001193125-25-285070 | Nov 17, 2025 | — |
| 3 | 3 | 0001193125-25-285069 | Nov 17, 2025 | Nov 10, 2025 |
| SCHEDULE 13G | — | 0000902664-25-004918 | Nov 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-273342 | Nov 10, 2025 | — |